One Plus One Equals Three: The Power of Patents + Trade Secrets
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
-
Lu par :
-
De :
À propos de ce contenu audio
In this second episode of the R² IP Podcast, host Ray Miller (Partner, DLA Piper) is joined once again by Nicole Endejann (Partner, DLA Piper), returning as a recurring guest to explore the nuanced dance between patents and trade secrets in life sciences and tech.
Is it patents or trade secrets? That binary thinking is out. The smartest companies are layering both—creating a force multiplier that delivers more than the sum of its parts.
Together, Ray and Nicole dive into:
- Why small molecule innovators still rely on patents—but secretly win on process know-how
- How biologics shift the IP battlefield to cell lines, culture conditions, and purification secrets
- What digital health, AI models, and data platforms can teach us about protecting code and training sets
- The rise of hybrid IP strategies—designed for speed, flexibility, and long-term advantage
Whether you’re patent-heavy, trade-secret-leaning, or somewhere in between, this episode offers fresh strategies and real-world examples to help you think smarter about your IP portfolio.
R² IP: Translating Intellectual Capital into IP—with insight, wit, and recurring guests who know their stuff.
DLA Piper
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !